Professional clinical review · English · RheumaView
Raynaud phenomenon and very early systemic sclerosis
Raynaud phenomenon is common; systemic sclerosis is not. Puffy fingers, a scleroderma capillary pattern and disease-specific antibodies change the context and justify focused assessment.
Start with the phenomenon
Clarify episodic colour change, cold or emotional triggers, duration, symmetry, pain and recovery. Photographs can help when the examination is normal. Persistent pallor, severe pain, tissue loss or a non-healing lesion requires a vascular assessment rather than routine reassurance. Review medications, occupational vibration, smoking and other causes of secondary Raynaud phenomenon.
Recognize an early pattern
Examine for puffy fingers, sclerodactyly, digital pits, telangiectasia and abnormal nailfold capillaries. Integrate ANA and SSc-specific serology with the history and examination. VEDOSS is a framework for recognizing and following an at-risk clinical pattern. Its cohort progression estimates are not a personal probability calculator for every individual with Raynaud phenomenon.
The original registry studied a selected population. Referral setting, combinations of findings, missing follow-up and the definition of progression matter when discussing its results. Neither a single antibody nor isolated nonspecific capillary changes should be converted into a diagnosis without clinical context.
Make uncertainty actionable
State whether the current picture favours primary Raynaud phenomenon, a possible evolving connective-tissue disease, or established SSc. Give a reason for any planned repeat examination or investigations. New puffy fingers, ulcers, skin tightening, unexplained breathlessness or objective weakness may change the assessment before a scheduled follow-up.
Classification and diagnosis
The ACR/EULAR classification framework supports consistent research populations. A person can warrant expert assessment before reaching a classification threshold, and a score should not override a better explanation for their findings. Clinical diagnosis, research classification and risk surveillance are related but distinct tasks.
Practical endpoint
The useful output is a documented phenotype, a proportionate investigation plan and explicit triggers for re-evaluation. Repeated broad antibody panels without a clinical question can amplify noise instead of improving this plan.
Practice with a clinical case
Related professional quiz · Open demo, no registration required · EN / RU / ES / PL.